Welcome to our dedicated page for Microvast Holdings SEC filings (Ticker: MVST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Microvast Holdings, Inc. (MVST) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and registration-related filings that together outline Microvast’s financial condition, governance, and capital markets activity.
Microvast is a battery technology company focused on lithium-ion solutions for electric vehicles and energy storage systems. Its filings describe key aspects of the business, such as revenue trends, gross margins, operating expenses, net income or loss, cash balances, and the use of non-GAAP measures like adjusted EBITDA, adjusted gross margin, and adjusted operating expenses. Risk factor sections and cautionary statements in these reports discuss uncertainties related to remaining a going concern, executing growth strategies, manufacturing capacity, supply chains, operations in China, litigation, regulatory changes, and macroeconomic and geopolitical conditions.
Current reports on Form 8-K capture material events such as quarterly earnings announcements, equity offering agreements, changes in executive leadership, and outcomes of annual stockholder meetings. For example, Microvast has filed 8-Ks describing the appointment of an interim chief financial officer, the departure of a chief financial officer, the results of its 2025 annual meeting, and the entry into a Controlled Equity OfferingSM Sales Agreement under an effective shelf registration statement.
The definitive proxy statement on Schedule 14A details corporate governance and stockholder matters, including board composition, director elections, auditor ratification, executive compensation, and voting procedures. Investors can also review information on the listing of Microvast’s common stock and redeemable warrants on the Nasdaq Capital Market under the symbols MVST and MVSTW.
Stock Titan’s platform enhances these filings with AI-powered summaries that explain the significance of lengthy reports, highlight important changes from prior periods, and surface key items such as revenue dynamics, risk disclosures, capital-raising transactions, and governance decisions. Users can quickly scan new 10-K, 10-Q, 8-K, and proxy filings, as well as monitor registered offerings and related legal opinions, without reading every page of the underlying documents.
Microvast Holdings, Inc. director Ying Wei received an equity award of 20,000 restricted stock units of common stock as part of the company’s non-employee director compensation policy. This is a grant, not an open-market purchase or sale, and carries no cash exercise price.
Each restricted stock unit represents a contingent right to receive one share of Microvast common stock. The units vest on December 31, 2026, subject to Ying Wei’s continued service on the board through that date. Following this award, Ying Wei directly holds a total of 388,789 shares of Microvast common stock.
Pan Yixin reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. director Pan Yixin received an equity award in the form of 20,000 shares of common stock on a grant basis. The award represents restricted stock units granted under the company’s non-employee director compensation policy at a price of $0.00 per share. Each restricted stock unit corresponds to one share of common stock and will vest on December 31, 2026, subject to continued board service through that date. Following this grant, Pan Yixin directly holds a total of 188,239 shares of Microvast common stock.
Wong Arthur Lap Tat reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings director Arthur Lap Tat Wong received an equity award rather than buying shares on the market. He was granted 20,000 restricted stock units under the non-employee director compensation policy, each equal to one common share. These units vest on December 31, 2026, assuming he continues to serve through that date. After this grant, he holds 237,473 common shares directly.
Microvast Holdings, Inc. Chief Operating Officer Wu Shengxian reported multiple equity-based compensation awards. The latest Form 4 shows grants of common stock and cash-settled restricted and performance stock units tied to the value of Microvast common shares.
The filing also reports a prior grant of an employee stock option covering 1,000,000 shares of common stock at an exercise price of $1.2900 per share, vesting in three equal installments starting on November 8, 2025 and expiring on December 5, 2034. Following the most recent grant on March 13, 2026, Wu directly holds 233,799 shares of common stock.
Microvast Holdings, Inc. describes a battery-technology business with advanced lithium-ion products for commercial vehicles and energy storage, but under significant financial strain. The company reported a net loss of $29.2 million in 2025, an accumulated deficit of $1,122.2 million, and acknowledges substantial doubt about its ability to continue as a going concern.
As of December 31, 2025, Microvast had stockholders’ equity of $410.5 million, cash and cash equivalents of $105.0 million, restricted cash of $64.3 million, and bank borrowings of $106.3 million, most due within 12 months, plus other sizable liabilities and purchase and capital commitments. Management plans to rely on operating cash flow, equity sales and refinancing, but notes there is no assurance these plans will be sufficient.
Operationally, Microvast positions itself as a vertically integrated battery manufacturer with proprietary cathode, anode, electrolyte and separator technologies, including LTO, NMC, LFP and early all-solid-state developments. Manufacturing capacity is concentrated in Huzhou, China, with smaller facilities in Germany and Tennessee, where a partially built U.S. plant has been suspended and is affected by mechanics liens and supplier disputes.
Microvast Holdings reported full-year 2025 revenue of $427.5 million, up 12.6% from 2024, with gross margin of 28.6% after a $32.5 million energy storage inventory impairment. The GAAP net loss narrowed sharply to $29.2 million from $195.5 million, while non-GAAP adjusted net profit reached $13.0 million and non-GAAP adjusted EBITDA improved to $44.7 million from a $44.8 million loss in 2024.
In Q4 2025, revenue was $96.4 million, down 15.0% year over year, and gross margin fell to 1.0% due to $29.0 million of impairment charges. Q4 GAAP net profit was $16.5 million, but non-GAAP adjusted net loss was $34.5 million. Cash, cash equivalents and restricted cash rose to $169.2 million as of December 31, 2025, from $109.6 million a year earlier.
Management expects continued revenue growth in 2026, targets maintaining a strong gross margin position, and is focused on achieving serial production at the Huzhou Phase 3.2 expansion and starting pack line operations in Clarksville, Tennessee by year-end, while pursuing high-barrier segments across EMEA, North America and APAC.
Mattis Wenjuan reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. Chief Technology Officer Mattis Wenjuan received 10,335 shares of common stock as a grant, with no cash paid per share. These shares were earned from performance stock units that vested based on achieving specified performance conditions over a defined performance period.
Following this award, Wenjuan directly holds 981,024 shares of Microvast common stock. The grant was certified by the company’s Compensation Committee on March 13, 2026, underscoring its link to previously established performance goals rather than an open-market purchase.
Microvast Holdings, Inc. reported that Chief Executive Officer and director Wu Yang acquired 93,135 shares of common stock as a compensation grant. The shares were earned from performance stock units that vested after the Compensation Committee certified achievement of the applicable performance conditions on March 13, 2026.
Following this award, Wu Yang directly holds 84,111,752 shares of Microvast common stock. The transaction was recorded at a price of $0.00 per share, reflecting that this was an incentive equity grant rather than an open‑market purchase.
Microvast Holdings, Inc. Chief Technology Officer Mattis Wenjuan acquired 112,500 shares of common stock on March 2, 2026 through a grant classified as a "grant, award, or other acquisition." These shares were earned from performance stock units that vested after achievement of performance conditions over the applicable period.
Following this equity award, Wenjuan directly owns 970,689 shares of Microvast common stock. The reported transaction carried a price per share of $0.0000, reflecting that it was compensation-based rather than an open-market purchase.
Ying Wei reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. director Ying Wei reported two equity awards of common stock in the form of restricted stock units granted under the company’s non-employee director compensation policy. These are compensation grants rather than open-market purchases or sales.
The first award covers 37,500 restricted stock units, each representing a right to receive one share of common stock, vesting on December 31, 2026, contingent on continued board service. The second award covers 30,357 restricted stock units, vesting in four equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, also subject to continued service.